-
Je něco špatně v tomto záznamu ?
European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms
KA. Rack, E. van den Berg, C. Haferlach, HB. Beverloo, D. Costa, B. Espinet, N. Foot, S. Jeffries, K. Martin, S. O'Connor, J. Schoumans, P. Talley, N. Telford, S. Stioui, Z. Zemanova, RJ. Hastings,
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, přehledy
NLK
ProQuest Central
od 2000-01-01 do Před 1 rokem
Open Access Digital Library
od 1997-01-01
Nursing & Allied Health Database (ProQuest)
od 2000-01-01 do Před 1 rokem
Health & Medicine (ProQuest)
od 2000-01-01 do Před 1 rokem
Public Health Database (ProQuest)
od 2000-01-01 do Před 1 rokem
- MeSH
- akutní myeloidní leukemie genetika MeSH
- chronická myeloidní leukemie MeSH
- hematologické nádory genetika MeSH
- hybridizace in situ fluorescenční MeSH
- lidé MeSH
- lymfom genetika MeSH
- mikročipová analýza MeSH
- mnohočetný myelom genetika MeSH
- myelodysplastické syndromy MeSH
- pruhování chromozomů MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Cytogenomic investigations of haematological neoplasms, including chromosome banding analysis, fluorescence in situ hybridisation (FISH) and microarray analyses have become increasingly important in the clinical management of patients with haematological neoplasms. The widespread implementation of these techniques in genetic diagnostics has highlighted the need for guidance on the essential criteria to follow when providing cytogenomic testing, regardless of choice of methodology. These recommendations provide an updated, practical and easily available document that will assist laboratories in the choice of testing and methodology enabling them to operate within acceptable standards and maintain a quality service.
Department of Clinical Genetics Erasmus MC University medical center Rotterdam The Netherlands
Department of Cytogenetics Nottingham University Hospital Nottingham UK
GenQA John Radcliffe Hospital Oxford University Hospitals NHS Trust Oxford UK
Haematological Malignancy Diagnostic Service St James's University Hospital Leeds UK
Hematopathology Section Hospital Clinic Barcelona Spain
MLL Munich Leukemia Laboratory Munich Germany
Oncogénomique laboratory Hematology department Lausanne University Hospital Vaudois Switzerland
Oncology Cytogenetics Service The Christie NHS Foundation Trust Manchester UK
Viapath Genetics laboratories Guys Hospital London UK
West Midlands Regional Genetics Laboratory Birmingham Women's Hospital Birmingham UK
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc19045024
- 003
- CZ-PrNML
- 005
- 20200113081616.0
- 007
- ta
- 008
- 200109s2019 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1038/s41375-019-0378-z $2 doi
- 035 __
- $a (PubMed)30696948
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Rack, K A $u GenQA, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, UK.
- 245 10
- $a European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms / $c KA. Rack, E. van den Berg, C. Haferlach, HB. Beverloo, D. Costa, B. Espinet, N. Foot, S. Jeffries, K. Martin, S. O'Connor, J. Schoumans, P. Talley, N. Telford, S. Stioui, Z. Zemanova, RJ. Hastings,
- 520 9_
- $a Cytogenomic investigations of haematological neoplasms, including chromosome banding analysis, fluorescence in situ hybridisation (FISH) and microarray analyses have become increasingly important in the clinical management of patients with haematological neoplasms. The widespread implementation of these techniques in genetic diagnostics has highlighted the need for guidance on the essential criteria to follow when providing cytogenomic testing, regardless of choice of methodology. These recommendations provide an updated, practical and easily available document that will assist laboratories in the choice of testing and methodology enabling them to operate within acceptable standards and maintain a quality service.
- 650 _2
- $a pruhování chromozomů $7 D002871
- 650 _2
- $a hematologické nádory $x genetika $7 D019337
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hybridizace in situ fluorescenční $7 D017404
- 650 _2
- $a chronická myeloidní leukemie $7 D015464
- 650 _2
- $a akutní myeloidní leukemie $x genetika $7 D015470
- 650 _2
- $a lymfom $x genetika $7 D008223
- 650 _2
- $a mikročipová analýza $7 D046228
- 650 _2
- $a mnohočetný myelom $x genetika $7 D009101
- 650 _2
- $a myelodysplastické syndromy $7 D009190
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a van den Berg, E $u Department of Genetics University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
- 700 1_
- $a Haferlach, C $u MLL-Munich Leukemia Laboratory, Munich, Germany.
- 700 1_
- $a Beverloo, H B $u Department of Clinical Genetics, Erasmus MC, University medical center, Rotterdam, The Netherlands.
- 700 1_
- $a Costa, D $u Hematopathology Section, Hospital Clinic, Barcelona, Spain.
- 700 1_
- $a Espinet, B $u Laboratori de Citogenètica Molecular, Servei de Patologia, Grup de Recerca,Translacional en Neoplàsies Hematològiques, Cancer Research Program, imim-Hospital del Mar, Barcelona, Spain.
- 700 1_
- $a Foot, N $u Viapath Genetics laboratories, Guys Hospital, London, UK.
- 700 1_
- $a Jeffries, S $u West Midlands Regional Genetics Laboratory, Birmingham Women's Hospital, Birmingham, UK.
- 700 1_
- $a Martin, K $u Department of Cytogenetics, Nottingham University Hospital, Nottingham, UK.
- 700 1_
- $a O'Connor, S $u Haematological Malignancy Diagnostic Service, St James's University Hospital, Leeds, UK.
- 700 1_
- $a Schoumans, J $u Oncogénomique laboratory, Hematology department, Lausanne University Hospital, Vaudois, Switzerland.
- 700 1_
- $a Talley, P $u Haematological Malignancy Diagnostic Service, St James's University Hospital, Leeds, UK.
- 700 1_
- $a Telford, N $u Oncology Cytogenetics Service, The Christie NHS Foundation Trust, Manchester, UK.
- 700 1_
- $a Stioui, S $u Laboratorio di Citogenetica e genetica moleculaire, Laboratorio Analisi, Humanitas Research Hospital, Rozzano, Milan, Italy.
- 700 1_
- $a Zemanova, Z $u Prague Center of Oncocytogenetics, Institute of Clinical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
- 700 1_
- $a Hastings, R J $u GenQA, John Radcliffe Hospital, Oxford University Hospitals NHS Trust, Oxford, UK. Ros.Hastings@ouh.nhs.uk.
- 773 0_
- $w MED00003138 $t Leukemia $x 1476-5551 $g Roč. 33, č. 8 (2019), s. 1851-1867
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30696948 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20200109 $b ABA008
- 991 __
- $a 20200113081948 $b ABA008
- 999 __
- $a ok $b bmc $g 1483293 $s 1083697
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2019 $b 33 $c 8 $d 1851-1867 $e 20190129 $i 1476-5551 $m Leukemia $n Leukemia $x MED00003138
- LZP __
- $a Pubmed-20200109